Aragen Life Sciences files DRHP with Sebi for IPO: ₹800 crore fresh issue plus OFS; proceeds for debt repayment and expansion. FY26 profit ₹257.6 crore.
This is a summary. For the full story, refer to the original source. Public of India presents verified citizen-relevant reporting.